Oncology

We understand that every person diagnosed with cancer is someone’s parent, sibling, or friend. This drives our discovery and development of medicines that matter most to people with cancer and their loved ones.


An Oncology Innovator Shaping Cancer Care for People Today and Tomorrow

Despite advances in prevention and treatment, cancer continues to take a heavy toll: more than 1.7 million Americans are expected to be diagnosed with cancer in 20181. Approximately 609,640 are expected to die from the disease –  that’s 1,670 of our friends and family members every day2.

Globally, the figures are far higher, with 14 million diagnoses and 8.2 million cancer-related deaths according to the most recent data3, with new cases predicted to rise to nearly 24 million per year by 20354.

Our Research

A potentially transformative pipeline

As these figures show, there is an urgent need for patients – particularly those with rare or hard-to-treat cancers – to have access to safe and efficacious medicines. We are investing significant resources into research and development in oncology and immuno-oncology, including into the promising area of DNA Damage Response (DDR). With our emphasis on biomarker-driven research, we aim to deliver personalized treatments and a potentially transformative pipeline.

We are among the first wave of pharmaceutical companies to leverage the potential of immuno-oncology treatments and are building on this foundation to develop next-generation oncolytics, including bifunctionals and bispecifics.

A wide range of partnerships

However, we know we cannot do this alone. While most of our pipeline molecules have been discovered in-house, we believe that scientific excellence requires a combination of knowledge, intuition and collaboration. We have partnerships with some of the best minds in the cancer community – from academia to leading cancer centers to industry – to help accelerate innovation for people with cancer.

We also understand that living with cancer encompasses more than medicines, and we actively seek feedback from physicians, patients and caregivers to understand and help support their needs and experiences beyond treatment.

Learn more about partnering with EMD Serono

Our Pipeline

Browse the programs in our pipeline to see what we're currently working on by phase, therapeutic area and compound type.

View Our Pipeline

Footnotes

1 American Cancer Society. Cancer Facts and Statistics 2018. Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. Accessed April 20, 2018.

2 American Cancer Society. Cancer Facts and Statistics 2018. Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. Accessed April 20, 2018.

3 American Cancer Society. Global Cancer Facts & Figures. Available at: https://www.cancer.org/research/cancer-facts-statistics/global.html. Accessed April 20, 2018

4 World Cancer Research Fund International (WCRF). Worldwide data. Available from: https://www.wcrf.org/int/cancer-facts-figures/worldwide-data. Accessed April 20, 2018.

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement